BobcatBio, Inc.
- Raised $5.3 million (2025)
- 1 clinical trial, 1 active
- Research grants: $4.8 million
- Founded 2020
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Castle Biosciences Inc
Nasdaq: CSTL
- Raised $10 million (2019)
- 5 clinical trials, 1 active
- Founded 2007
ENvue Medical, Inc.
Nasdaq: FEED
- Raised $14 million (2023)
- 2 clinical trials
Immunomic Therapeutics, Inc.
- Raised $6.5 million (2025)
- 9 clinical trials, 2 active
- Research grants: $749,717
Integra Lifesciences Corporation
- 83 clinical trials, 6 active
- FDA-cleared or approved devices
- Research grants: $222,799
Kiora Pharmaceuticals Inc
Nasdaq: KPRX
- Raised $5 million (2026)
- 5 clinical trials, 2 active
- Founded 2004
NexEos Diagnostics, Inc.
- Raised $3 million (2026)
- 1 clinical trial
- Research grants: $1.8 million
- Founded 2019
Rebel Medicine Inc
- Raised $8.8 million (2026)
- 1 clinical trial, 1 active
- Research grants: $1.1 million
- Founded 2020
CardioFocus, Inc.
- Raised $8 million (2019)
- 11 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $290,799
GelSana Therapeutics, Inc.
- Raised $3.5 million (2026)
- 1 FDA-registered device site
- Research grants: $1.2 million
- Founded 2020
Kalogon, Inc.
- Raised $5.7 million (2026)
- 1 clinical trial
- 1 FDA-registered device site
- Research grants: $674,746
Precision Optics Corporation, Inc.
Nasdaq: POCI
- Raised $2.5 million (2023)
- 1 FDA-registered device site
Cyclo Therapeutics, Inc.
- Raised $2.8 million (2020)
- 6 clinical trials
- 1 FDA-registered drug site
Faeth Therapeutics, Inc.
Nasdaq: FTH
- Raised $349 million (2026)
- 10 clinical trials, 2 active
Processa Pharmaceuticals, Inc.
Nasdaq: PCSA
- Raised $10 million (2021)
- 10 clinical trials, 1 active
STERIS plc
NYSE: STE
- 2 FDA-registered device sites
- 1 FDA-registered drug site
Aptitude Medical Systems Inc
- 3 clinical trials, 2 active
- 1 FDA-registered device site
- Research grants: $22 million
NeuroMetrix, Inc.
- Raised $19 million (2009)
- 1 clinical trial
- FDA-cleared or approved devices
NinePoint Medical, Inc.
- Raised $31 million (2015)
- 6 clinical trials
- Research grants: $1.7 million
- Founded 2008
Progentec Diagnostics, Inc.
- Raised $2.5 million (2018)
- 2 clinical trials
- Research grants: $7.9 million
- Founded 2015
Antares Pharma, Inc.
- 9 clinical trials
- 1 FDA-registered device site
- 1 FDA-registered drug site
Soterix Medical, Inc.
- 11 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $10 million
Biogen Inc.
Nasdaq: BIIB
- 544 clinical trials, 43 active
- 2 FDA-registered drug sites
C. R. Bard, Inc.
- 119 clinical trials, 10 active
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
Regeneron Pharmaceuticals, Inc.
Nasdaq: REGN
- 608 clinical trials, 149 active
- 2 FDA-registered drug sites
AIM ImmunoTech Inc.
NYSE: AIM
- Raised $3.3 million (2024)
- 9 clinical trials
Aptevo Therapeutics Inc.
Nasdaq: APVO
- Raised $2.1 million (2025)
- 9 clinical trials, 1 active
Aytu Biopharma, Inc
Nasdaq: AYTU
- Raised $10 million (2019)
- 4 clinical trials
- Founded 2015
Bolt Biotherapeutics, Inc.
Nasdaq: BOLT
- Raised $15 million (2021)
- 4 clinical trials, 1 active
- Founded 2015
Decoy Therapeutics Inc.
Nasdaq: DCOY
- Raised $6 million (2023)
- 4 clinical trials, 1 active
- Founded 2014
Ensysce Biosciences, Inc.
Nasdaq: ENSC
- Raised $2.2 million (2025)
- 9 clinical trials, 2 active
Entrada Therapeutics, Inc.
Nasdaq: TRDA
- Raised $116 million (2021)
- 4 clinical trials, 3 active
- Founded 2016
Genprex, Inc.
Nasdaq: GNPX
- Raised $10 million (2018)
- 4 clinical trials, 2 active
- Founded 2009
Nuvectis Pharma, Inc.
Nasdaq: NVCT
- Raised $16 million (2022)
- 4 clinical trials, 3 active
- Founded 2020
Q/C Technologies, Inc.
Nasdaq: QCLS
- Raised $7 million (2025)
- 4 clinical trials, 1 active
- Founded 2023
Aromha, Inc.
- Raised $250,000 (2025)
- 1 FDA-registered device site
- Research grants: $11 million
- Founded 2020
Adjuvance Technologies Inc.
- Raised $11 million (2019)
- 1 clinical trial
- Research grants: $5.4 million
Agitated Solutions, Inc.
- Raised $6.5 million (2025)
- 1 clinical trial, 1 active
- Research grants: $1.2 million
- Founded 2020
Akari Therapeutics Plc
Nasdaq: AKTX
- Raised $1.8 million (2026)
- 8 clinical trials
Celularity Inc
Nasdaq: CELU
- Raised $2 million (2025)
- 17 clinical trials
- Founded 2016
REBISCAN, Inc.
- 11 clinical trials, 3 active
- FDA-cleared or approved devices
- Research grants: $7.6 million
Spinal Singularity, Inc.
- Raised $2 million (2018)
- 5 clinical trials
- Research grants: $3.4 million
- Founded 2015
Sutro Biopharma, Inc.
Nasdaq: STRO
- Raised $85 million (2018)
- 9 clinical trials, 2 active
BioAesthetics Corp
- Raised $6.4 million (2021)
- 1 clinical trial
- Research grants: $5.7 million
- Founded 2017
IVERIC bio, Inc.
- Raised $11 million (2018)
- 16 clinical trials
- Founded 2007
Cellerant Therapeutics Inc
- Raised $6.5 million (2019)
- 3 clinical trials
- Research grants: $7.9 million
Advanced Tactile Imaging Inc
- 5 clinical trials
- FDA-cleared or approved devices
- Research grants: $14 million
Lantheus Medical Imaging, Inc.
- 30 clinical trials, 5 active
- 1 FDA-registered device site
- 1 FDA-registered drug site
Point Designs, Inc.
- 8 clinical trials, 2 active
- 1 FDA-registered device site
- Research grants: $21 million
Avalyn Pharma Inc.
Nasdaq: AVLN
- Raised $189 million (2023)
- 3 clinical trials, 3 active
- Founded 2011
Published company profiles only; counts update daily. Data licences